BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15710101)

  • 1. [Multiple endocrine neoplasia 2A type: a genetic study of one family].
    Arias Miranda IM; Casal Alvarez F; Castaño L
    Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic thyroidectomy in MEN 2A syndrome.
    Mattavelli F; Seregni E; Collini P; Pasini B; Aiello A; Barbaccia C; Bimbi G; Riccio S; Santamaria S
    Tumori; 2003; 89(5):553-5. PubMed ID: 14870785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ; Mulligan LM
    Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract]   [Full Text] [Related]  

  • 4. The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case.
    Aiello A; Cioni K; Gobbo M; Collini P; Gullo M; Della Torre G; Passerini E; Ferrando B; Pilotti S; Pierotti MA; Pasini B
    Surgery; 2005 May; 137(5):574-6. PubMed ID: 15855933
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2A in Chinese families.
    Lo CY; Wat NM; Lam KY; Tiu SC; Chan J; Lam KS
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):528. PubMed ID: 12641638
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of DNA-based testing in a large Canadian family with multiple endocrine neoplasia type 2.
    Gilchrist DM; Morrish DW; Bridge PJ; Brown JL
    Clin Genet; 2004 Oct; 66(4):349-52. PubMed ID: 15355438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medullary cancers of the thyroid: genetic aspects].
    Orgiazzi J
    Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251
    [No Abstract]   [Full Text] [Related]  

  • 10. [RET mutations and preventive treatment of medullary thyroid cancer].
    Niccoli-Sire P; Conte-Devolx B;
    Ann Endocrinol (Paris); 2005 Jun; 66(3):168-75. PubMed ID: 15988377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
    Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
    Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.
    Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S
    Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370
    [No Abstract]   [Full Text] [Related]  

  • 13. Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A.
    Gibelin H; Bezieau S; Misso C; Bouin-Pineau MH; Maréchaud R; Kraimps JL
    Br J Surg; 2004 Nov; 91(11):1458-9. PubMed ID: 15386323
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
    Neocleous V; Passalaris T; Spanou E; Kitsios P; Skordis N; Deltas CC
    Genet Test; 2004; 8(2):163-8. PubMed ID: 15345114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
    Sasaki Y; Shimotake T; Go S; Iwai N
    Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children.
    van Heurn LW; Schaap C; Sie G; Haagen AA; Gerver WJ; Freling G; van Amstel HK; Heineman E
    J Pediatr Surg; 1999 Apr; 34(4):568-71. PubMed ID: 10235324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from the management of a rare genetic cancer.
    Cote GJ; Gagel RF
    N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.